Drug intelligence / Profile preview

betamethasone valerate + calcipotriol

Development stage
Unknown
Lead developer
MC2 Therapeutics
Modality
Small Molecules
Administration
Topical
01

Overview

Betamethasone valerate + calcipotriol is a fixed-dose combination medication used for the treatment of plaque psoriasis. It combines two active ingredients with complementary mechanisms of action: betamethasone valerate (a corticosteroid) and calcipotriol (a vitamin D analog). Betamethasone valerate reduces inflammation, redness, itching, and swelling by blocking the production of inflammatory chemical messengers. Calcipotriol works by slowing down the excessive growth of skin cells that build up to form psoriasis plaques. The combination provides greater efficacy than either component used alone, with a more favorable safety profile as calcipotriol can mitigate the skin-thinning effects of betamethasone, while betamethasone can reduce the skin irritation sometimes caused by calcipotriol.

Other names
betamethasone and calcipotrienebetamethasone 17-valerate and calcipotriolbetamethasone17-valerate and calcipotriolbetamethasone-17-valerate and calcipotriol
02

Targets

GR (Glucocorticoid receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on betamethasone valerate + calcipotriol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone valerate + calcipotriol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call